Mathieu Guillot

Mathieu Guillot

Auto-generated profile, based on publicly available information

Mathieu Guillot

Département de radio-oncologie, Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Québec, J1H 5N4, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Medical Physics
Verified
Journal Article
Closed access
JCJulie Constanzo
Julie Constanzo
BPBenoit Paquette
Benoit Paquette
Gabriel CharestGabriel Charest
Gabriel Charest
LMLaurence Masson-Cote
Laurence Masson-Cote
MGMathieu Guillot
Mathieu Guillot

1 August 2020 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
RLRémi Lessard
Rémi Lessard
NTNicolas M. Tremblay
Nicolas M. Tremblay
MPMarc‐Émile Plourde
Marc‐Émile Plourde
MGMathieu Guillot
Mathieu Guillot
Purpose To present an open-source software () for monitoring intrafraction motion that is based on the visualization of superimposed contours of projected region-of-interests from DICOM RTSTRUCT files on cine-MV images acquired and displayed in real-time during radiation therapy delivery. Clinical use with prostate gold fiducial markers is presented. Methods Projections of regions of interest (ROI) in the reference frame of the electronic portal imaging device are computed offline for different gantry angles before the first treatment fraction. During treatment delivery, the contrast of portal images is automatically adjusted using a histogram equalization algorithm. The projections associated with the current gantry angle are then superimposed on the images in real time. This allows the therapist to evaluate if the imaged structures of interest remain within their respective contours during treatment delivery and to potentially interrupt the treatment if deemed necessary. The spatial accuracy of the method was evaluated by imaging a ball bearing phantom in a set-up where the position of the projected ROI is highly sensitive to gantry angle errors. The visibility of fiducial markers during one fraction of seven different volumetric modulated arc therapy (VMAT) prostate treatments is characterized. Results The geometric validation showed a negligible systematic error mu < 0.1 mm for the position of the projections. The random errors associated with the time accuracy of the gantry angle readout were characterized by standard deviations sigma <= 0.6 mm. The VMAT clinical treatments showed that the fiducial markers were frequently visible, allowing for a meaningful clinical use. Conclusions The results demonstrate that the method presented is sufficiently accurate to be used for intrafraction monitoring of patients. The fact that this method could be implemented on many modern linacs at little to no cost and with no additional dose delivered to the patients makes this solution very attractive for improving patient care and safety in radiation therapy.